✦ LIBER ✦

P-795 Phase III study comparing cyclophosphamide, doxorubicin, and etoposide (CDE) to carboplatin and paclitaxel (CP) in patients (pts) with extensive disease small cell lung cancer (ED SCLC)

✍ Scribed by Smit, E.; Groen, H.; Biesma, B.; vd Wilt, C.; Koolen, M.; de Jong, W.; van Tinteren, H.; van Bochove, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III study of cyclophosphamide, dox

✍ Wouter K. de Jong; Harry J.M. Groen; Mia G.J. Koolen; Bonne Biesma; Luuk N.A. Wi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 178 KB

P-563 Phase I study of sequential topote

✍ Miller, Antonius A.; Tucker, Robert; Lesser, Glenn; Case, Doug 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

P-766 Phase II study of topotecan (T) an

✍ Hainsworth, J.; Palmer, M.; Granick, J.; Boston, B.; Bonomi, P.; Althouse, D.; D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

A phase II study of paclitaxel (P) and c

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Phase-II trial of Etoposide (E) and Carb

✍ Garfield, D.; Dakhil, S.; Abubakr, Y.; Kruger, S.; Frank, S. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A randomized phase III study of irinotec

✍ Negoro, S; Noda, K; Nishiwaki, Y; Kawahara, M; Tamura, T; Sugiura, T; Yokayama, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB